Medication info
Omethan Plus Tablet 20/12.5 mg

Omethan Plus Tablet 20/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Light orange colored round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100889 · Approved 2011.02.24 · Insurance code 650302770

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
Before administering this medicine, it is recommended that the dose of olmesartan medoxomil or hydrochlorothiazide be adjusted separately. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this medicine once daily, regardless of meals. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is coadministered or when switching to this medicine (olmesartan medoxomil/hydrochlorothiazide) in patients taking high doses of hydrochlorothiazide alone and in patients with volume depletion or hyponatremia. In such cases, reduce the dose of hydrochlorothiazide to 12.5mg before coadministering olmesartan medoxomil. In older adults, start with the lowest dose and use caution when adjusting the dose, taking the patient's renal or cardiac function, comorbidities, and other concomitant medications into consideration. This medicine (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal failure (creatinine clearance>30mL/min). Do not administer this medicine (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal failure, as loop diuretics are preferable to thiazide diuretics in these patients. Use of this medicine is not recommended because there is no experience with its use in patients with hepatic failure.
Child dose
The safety▪efficacy in children have not been established.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension who do not achieve adequate control with monotherapy using Olmesartan Medoxomil and Hydrochlorothiazide. Essential hypertension is a rise in blood pressure that occurs without a specific cause, making continuous treatment important. This drug helps stabilize blood pressure by dilating blood vessels and promoting the excretion of salt, thus reducing cardiovascular risk. Patients should take this medication consistently as prescribed to significantly aid in blood pressure control. Therefore, this drug is used for the treatment of essential hypertension.

How to take

Adult dose

Before administering this medicine, it is recommended that the dose of olmesartan medoxomil or hydrochlorothiazide be adjusted separately. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this medicine once daily, regardless of meals. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is coadministered or when switching to this medicine (olmesartan medoxomil/hydrochlorothiazide) in patients taking high doses of hydrochlorothiazide alone and in patients with volume depletion or hyponatremia. In such cases, reduce the dose of hydrochlorothiazide to 12.5mg before coadministering olmesartan medoxomil. In older adults, start with the lowest dose and use caution when adjusting the dose, taking the patient's renal or cardiac function, comorbidities, and other concomitant medications into consideration. This medicine (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal failure (creatinine clearance>30mL/min). Do not administer this medicine (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal failure, as loop diuretics are preferable to thiazide diuretics in these patients. Use of this medicine is not recommended because there is no experience with its use in patients with hepatic failure.

Child dose

The safety▪efficacy in children have not been established.

Precautions

This medication may cause serious harm to the fetus and newborn if administered to pregnant women in the second and third trimesters, so treatment should be stopped immediately upon confirmation of pregnancy. Patients who are allergic to the components of this drug or who have specific kidney or liver conditions, as well as pregnant or breastfeeding women, should not use this medication. Patients with reduced blood volume, weakened kidney function, or renal artery stenosis should use this drug with special caution, as hypotension or changes in kidney function may occur; thus, their condition should be closely monitored. This medication can cause electrolyte imbalance, so regular blood tests should be performed to check levels of sodium, potassium, etc. If symptoms such as dizziness or muscle cramps occur, you should inform your healthcare provider immediately. Caution is needed when using this medication with other drugs, so if you are currently taking any other medications, be sure to inform your doctor or pharmacist, especially if potassium supplements, diuretics, lithium medications, or non-steroidal anti-inflammatory drugs will be used in combination. This drug should be administered cautiously to the elderly or children, as safety in pediatrics has not been established. If breastfeeding, this medication can be transferred to breast milk, which may cause adverse reactions in infants, so administration should be avoided or breastfeeding should be discontinued. Overdosage of this medication can lead to hypotension, palpitations, electrolyte imbalance, etc., so strict adherence to dosing is necessary, and if any unusual symptoms occur, you should visit a medical institution immediately. Additionally, while taking this medication, care should be taken to avoid excessive sun exposure, and you should consult your doctor immediately if any skin abnormalities occur.

Side effects

Nausea, hyperuricemia, dizziness, upper respiratory tract infection, headache, urinary tract infection, chest pain, back pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastritis, diarrhea, elevated AST, elevated GGT, elevated ALT, hyperlipidemia, elevated creatine phosphokinase, hyperglycemia, arthritis, arthralgia, myalgia, cough, rash, hematuria, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, rhabdomyolysis, acute renal failure, increased serum creatinine, hair loss, pruritus, urticaria, hyponatremia, increased urinary frequency, palpitations, headache, fatigue, drowsiness, emotional blunting, restlessness, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, orthostatic hypotension, arrhythmia, temporary blurred vision, jaundice, choroidal exudate, jaundice, hepatitis, acute cholecystitis, necrotizing vasculitis, vasculitis, cutaneous vasculitis, facial flushing, photosensitivity, autoimmune hepatitis, chronic malabsorption syndrome, intestinal vascular edema, lethargy, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, hypercalcemia, muscle cramps, paresthesia, weakness, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, toxic epidermal necrolysis, thrombocytopenia, leukopenia, aplastic anemia, hemolytic anemia, purpura, anorexia, thirst, abdominal discomfort, constipation, abdominal colic, pancreatitis, jaundice, sialadenitis, dry mouth, abnormal liver function tests, elevated blood pressure, epistaxis, asthma, low blood pressure, palpitations, bradycardia, electrolyte deficiency, dehydration, nausea, drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 and 25 degrees Celsius at room temperature. This will help maintain the drug's effectiveness and allow for safe use.

Appearance and packaging

Appearance

Light orange colored round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.